MedPAC urges fix for charge compression
This article was originally published in The Gray Sheet
Executive Summary
CMS should immediately correct for charge compression, a payment calculation phenomenon that generally leads to the undervaluing of high-cost technology, says the Medicare Payment Advisory Commission in Sept. 14 1comments to the agency. Despite similar pressure from device stakeholders to use regression analysis for a near-term fix to the problem, CMS said in its July proposal for 2008 hospital outpatient payments that it wants to further study the approach (2"The Gray Sheet" July 23, 2007, p. 17). "The issue of charge compression is serious enough that CMS should move forward with this imperfect solution," MedPAC writes. CMS will finalize the decision by Nov. 1
You may also be interested in...
CMS Declines To Act On Charge Compression In 2008 Outpatient Proposal
CMS wants to examine hospital outpatient charge data more carefully before making any Medicare payment adjustments to remedy charge compression, the agency explains in its 2008 outpatient payment proposed 1rule
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.